Loading stock data…
$205.56+1.19 (+0.58%)
Nutex Health Inc.
Nutex Health Inc. in the Healthcare sector is trading at $204.36 with a market capitalization of $1.5B. Wall Street consensus targets $288.20 (5 analysts), implying a +41.0% move over the next 12 months. The stock is currently near its 52-week high of $226.16, remaining 37.5% above its 200-day moving average. On fundamentals, Piotroski 7/9 indicates strong financial quality, Altman Z in the safe zone. The Whystock Score of 100/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $210.75M↓ | $216.49M↑ | $151.68M↓ | $267.80M↑ | $243.99M |
| Gross Profit | $141.28M↑ | $91.73M↑ | $46.14M↓ | $154.88M↑ | $124.92M |
| Operating Income | $121.72M↑ | $81.27M↑ | $30.92M↓ | $130.37M↑ | $33.68M |
| Net Income | $65.84M↑ | $46.81M↑ | $11.83M↓ | $55.44M↑ | -$17.70M |
Nutex Health Inc. operates as a healthcare services and operations company in the United States. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The Hospital segment develops and operates a network o...